BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sánchez-Fernández P, Riobello C, Costales M, Vivanco B, Cabal VN, García-Marín R, Suárez-Fernández L, López F, Cabanillas R, Hermsen MA, Llorente JL. Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma. Sci Rep 2021;11:2247. [PMID: 33500480 DOI: 10.1038/s41598-020-80242-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 López F, Mäkitie A, de Bree R, Franchi A, de Graaf P, Hernández-Prera JC, Strojan P, Zidar N, Strojan Fležar M, Rodrigo JP, Rinaldo A, Centeno BA, Ferlito A. Qualitative and Quantitative Diagnosis in Head and Neck Cancer. Diagnostics (Basel) 2021;11:1526. [PMID: 34573868 DOI: 10.3390/diagnostics11091526] [Reference Citation Analysis]
2 García-Marín R, Cabal VN, Fernández-Cedrón Bermejo C, Riobello C, Suárez-Fernández L, Codina-Martínez H, Navarro-García A, Lorenzo-Guerra SL, García-Martínez J, Vivanco B, López F, Llorente JL, Hermsen MA. A Novel External Auditory Canal Squamous Cell Carcinoma Cell Line Sensitive to CDK4/6 Inhibition. Otolaryngol Head Neck Surg 2022;:1945998221089186. [PMID: 35349366 DOI: 10.1177/01945998221089186] [Reference Citation Analysis]
3 Riobello C, Casanueva Muruais R, Suárez-Fernández L, García-Marín R, Cabal VN, Blanco-Lorenzo V, Franchi A, Laco J, López F, Llorente JL, Hermsen MA. Intragenic NF1 deletions in sinonasal mucosal malignant melanoma. Pigment Cell Melanoma Res 2021. [PMID: 34547192 DOI: 10.1111/pcmr.13015] [Reference Citation Analysis]
4 Taverna C, Agaimy A, Franchi A. Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities. Cancers 2022;14:1463. [DOI: 10.3390/cancers14061463] [Reference Citation Analysis]
5 Riobello C, Sánchez-Fernández P, Cabal VN, García-Marín R, Suárez-Fernández L, Vivanco B, Blanco-Lorenzo V, Álvarez Marcos C, López F, Llorente JL, Hermsen MA. Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma. Cancers (Basel) 2021;13:5022. [PMID: 34638506 DOI: 10.3390/cancers13195022] [Reference Citation Analysis]
6 Hieggelke L, Heydt C, Castiglione R, Rehker J, Merkelbach-Bruse S, Riobello C, Llorente JL, Hermsen MA, Buettner R. Mismatch Repair Deficiency and Somatic Mutations in Human Sinonasal Tumors. Cancers (Basel) 2021;13:6081. [PMID: 34885191 DOI: 10.3390/cancers13236081] [Reference Citation Analysis]
7 Turri-zanoni M, Gravante G, Castelnuovo P. Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment. Curr Oncol Rep. [DOI: 10.1007/s11912-021-01154-3] [Reference Citation Analysis]
8 Lopez DC, Wadley AE, London NR Jr. Emerging concepts in sinonasal tumor research. Curr Opin Otolaryngol Head Neck Surg 2022;30:33-9. [PMID: 34958321 DOI: 10.1097/MOO.0000000000000776] [Reference Citation Analysis]
9 Re M, Tomasetti M, Monaco F, Amati M, Rubini C, Sollini G, Bajraktari A, Gioacchini FM, Santarelli L, Pasquini E. MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma. Head Neck 2021. [PMID: 34647653 DOI: 10.1002/hed.26894] [Reference Citation Analysis]